Sreenivasa joined GeoVax in 2020 with twenty years of research experience in molecular cell biology and immunology. Under the mentorship of Dr. Thomas Grundstrom at Umea University (Sweden), he completed a Ph.D. in Molecular Biology on the regulation of NF-kB transcription factor by calcium signaling in T cells. In 2011, he pursued postdoctoral training in the laboratory of Dr. Judy Cannon at the University of New Mexico, where he acquired knowledge of T cell immunology through research about T cell migration, both in cancer and infection models. He is a key member of the research and development team at GeoVax and assists in developing and accessing vaccine efficacy and immunogenicity.